Join the Melanoma group to help and get support from people like you.
Melanoma News
Related terms: Cancer, Melanoma, Malignant Melanoma, Skin Cancer, Melanoma
Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma
WEDNESDAY, April 16, 2025 – Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify patients with melanoma and a high risk for...
Blood Test Can Predict Melanoma Recurrence
WEDNESDAY, April 16, 2025 – A new blood test can help predict if melanoma survivors will have a future bout with skin cancer, researchers say. The test looks for DNA fragments that are shed by...
Common Photosensitizing Drugs Increase Skin Cancer Risk
TUESDAY, April 1, 2025 – Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & ...
Many U.S. Adults Still Have Misconceptions About Skin Cancer Risk
WEDNESDAY, March 26, 2025 – About two-thirds of U.S. adults report no sunburns in the past year, with significant associations seen between the number of sunburns and sociodemographic factors,...
Adding 3D Total Body Photography to Usual Care Increases Rate of Skin Excisions
WEDNESDAY, March 26, 2025 – The addition of three-dimensional (3D) total-body photography (TBP) and sequential digital dermoscopy imaging (SDDI) via teledermatology to usual care increases the...
FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
FRIDAY, Jan. 3, 2025 – The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid...
FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications
PRINCETON, N.J.--(BUSINESS WIRE) December 27, 2024 – Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) granted approval for Opdivo Qvantig (nivolumab...
Thicker Melanoma Tumor Size Tied to Higher Risk of 20-Year Melanoma-Related Death
FRIDAY, Dec. 13, 2024 – Risk of 20-year melanoma-related death increases significantly for patients with primary tumors of 0.8 to 1.0 mm in thickness, according to a study published online Dec. 11...
Characteristics Differ for Melanomas in Children, Teens, Young Adults
TUESDAY, Nov. 26, 2024 – Tumor characteristics differ significantly among pediatric and adolescent and young adult (AYA) patients with melanoma, with decreasing incidence rates seen among young...
Teledermoscopy Accurate for Detecting Skin Cancers
WEDNESDAY, Nov. 20, 2024 – Teledermoscopy has high accuracy for detecting skin cancers, according to a research letter published online Nov. 9 in the Journal of the American Academy of Dermatology....
Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
THURSDAY, Nov. 7, 2024 – There is a negative association between travel time to tanning facilities and county-level melanoma incidence rates, according to a study published online Nov. 7 in the...
Cutaneous Malignant Melanoma Incidence Increasing Among the Elderly
THURSDAY, Nov. 7, 2024 – From 1987 to 2016, there was a considerable increase in the incidence of cutaneous malignant melanoma (CMM) among the elderly in the United States, according to a study...
New Set of Risk Factors Can Boost Detection of Suspicious Skin Lesions
MONDAY, Nov. 4, 2024 – A new set of skin cancer risk factors can improve detection of suspicious skin lesions, according to a study published online Sept. 6 in Scientific Reports. Shafiqul Islam,...
Risk for Second Melanoma Up for Those With First Melanoma Diagnosis
WEDNESDAY, Oct. 9, 2024 – Patients with a first melanoma diagnosis have an increased risk for a second melanoma diagnosis, regardless of race and ethnicity, according to a research letter published...
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
WEDNESDAY, Oct. 2, 2024 – Circulating antibodies against cancer-testis antigens (CTAgs) are found in stage I and stage II melanoma plasma samples, according to a study presented at the annual...